Clinical Trials Directory

Trials / Completed

CompletedNCT02674685

Vfend Special Investigation For Prophylaxis

VFEND SPECIAL INVESTIGATION FOR PROPHYLAXIS

Status
Completed
Phase
Study type
Observational
Enrollment
241 (actual)
Sponsor
Pfizer · Industry
Sex
All
Age
0 Years
Healthy volunteers
Not accepted

Summary

Examine the safety and effectiveness of Vfend \[voriconazole\] for prophylaxix use under general clinical practices.

Conditions

Timeline

Start date
2016-03-11
Primary completion
2019-07-03
Completion
2019-07-03
First posted
2016-02-04
Last updated
2023-04-25
Results posted
2020-07-23

Source: ClinicalTrials.gov record NCT02674685. Inclusion in this directory is not an endorsement.